Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.19 | 0.42% | 0.01 |
ACRS closed unchanged on Wednesday, May 15, 2024, on 75 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Jun 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gapped Up | Strength | 0.42% | |
| Oversold Stochastic | Weakness | 0.42% | |
| 20 DMA Resistance | Bearish | 0.42% | |
| 50 DMA Resistance | Bearish | 0.42% | |
| MACD Bearish Centerline Cross | Bearish | 0.42% | |
| Oversold Stochastic | Weakness | 0.42% | |
| Stochastic Reached Oversold | Weakness | 0.42% | |
| Oversold Stochastic | Weakness | 0.42% | |
| 20 DMA Resistance | Bearish | 1.28% | |
| 50 DMA Resistance | Bearish | 1.28% |
| Alert | Time |
|---|---|
| Possible NR7 | about 1 hour ago |
| Possible Inside Day | about 1 hour ago |
| 60 Minute Opening Range Breakout | about 3 hours ago |
| Possible NR7 | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/06/2024
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Hydrogen Peroxide Stage Specialty Pharmaceutical Topical Medication Common Warts Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.12 |
| 52 Week Low | 0.5902 |
| Average Volume | 838,337 |
| 200-Day Moving Average | 3.18 |
| 50-Day Moving Average | 1.23 |
| 20-Day Moving Average | 1.23 |
| 10-Day Moving Average | 1.25 |
| Average True Range | 0.07 |
| RSI (14) | 43.82 |
| ADX | 14.61 |
| +DI | 18.07 |
| -DI | 18.86 |
| Chandelier Exit (Long, 3 ATRs) | 1.18 |
| Chandelier Exit (Short, 3 ATRs) | 1.36 |
| Upper Bollinger Bands | 1.34 |
| Lower Bollinger Band | 1.12 |
| Percent B (%b) | 0.26 |
| BandWidth | 17.89 |
| MACD Line | -0.01 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.0113 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.25 | ||||
| Resistance 3 (R3) | 1.25 | 1.23 | 1.24 | ||
| Resistance 2 (R2) | 1.23 | 1.21 | 1.23 | 1.23 | |
| Resistance 1 (R1) | 1.21 | 1.20 | 1.20 | 1.20 | 1.23 |
| Pivot Point | 1.19 | 1.19 | 1.18 | 1.18 | 1.19 |
| Support 1 (S1) | 1.16 | 1.17 | 1.15 | 1.16 | 1.13 |
| Support 2 (S2) | 1.14 | 1.16 | 1.14 | 1.13 | |
| Support 3 (S3) | 1.12 | 1.14 | 1.12 | ||
| Support 4 (S4) | 1.11 |
